Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor? 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor? 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections^4,6,7 and formalin-fixed paraffin-embedded sections¹¹, immunoprecipitation¹, activation of T cells^2,3,5, Western blotting⁹, and spatial biology (IBEX)^16,17. The LEAF? purified antibody (Endotoxin < 0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 300413, 300414, and 300432). For highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 300437, 300438, 300465, 300466, 300473, 300474) with a lower endotoxin limit than standard LEAF? purified antibodies (Endotoxin < 0.01 EU/?g).

1. Salmeron A, et al. 1991. J. Immunol. 147:3047. (IP)
2. Graves J, et al. 1991. J. Immunol. 146:2102. (Activ)
3. Lafont V, et al. 2000. J. Biol. Chem. 275:19282. (Activ)
4. Ryschich E, et al. 2003. Tissue Antigens 62:48. (IHC)
5. Thompson AG, et al. 2004. J. Immunol. 173:1671. (Activ)
6. Sakkas LI, et al. 1998. Clin. Diagn. Lab. Immun. 5:430. (IHC)
7. Mack CL, et al. 2004. Pediatr. Res. 56:79. (IHC)
8. Thakral D, et al. 2008. J. Immunol. 180:7431. (FC) PubMed
9. Van Dongen JJM, et al. 1988. Blood 71:603. (WB)
10. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
11. Pollard, K. et al. 1987. J. Histochem. Cytochem. 35:1329. (IHC)
12. Luckashenak N, et al. 2013. J. Immunol. 190:27. PubMed
13. Laurent AJ, et al. 2014. PLoS One. 9:103683. PubMed
14. Li J, et al. 2015. Cancer Res. 75:508. PubMed
15. Stoeckius M, et al. 2017. Nat. Methods. 14:865-868. (PG)
16. Radtke AJ,?et al. 2020.?Proc Natl Acad Sci USA. 117:33455-33465. (SB)?PubMed
17. Radtke AJ,?et al. 2022.?Nat Protoc. 17:378-401. (SB)?PubMed

1. Laprevotte E, et al. 2013. Leuk Res. 37:440. PubMed
2. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
3. Iwahori K, et al. 2019. Sci Rep. 2.205555556. PubMed
4. Chiu YL, et al. 2018. Immun Ageing. 15:27. PubMed
5. Ivan Jelcic et al. 2018. Cell. 175(1):85-100 . PubMed
6. Serra–Peinado C, et al. 2019. Nat Commun. 10:3705. PubMed
7. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
8. Walsh RE, et al. 2020. MAbs. 12:1764829. PubMed
9. Mashiko S, et al. 2015. J Allergy Clin Immunol. 136: 351-359. PubMed
10. Keustermans G,et al. 2017. PLoS One. 10.1371/journal.pone.0187068. PubMed
11. Di Blasi D, et al. 2019. Cell Mol Gastroenterol Hepatol. 0.510416667. PubMed
12. Jacobs ME, et al. 2021. Immunother Adv. 1:ltaa004. PubMed
13. Sundstr?m P, et al. 2015. J Immunol. 195: 3472 - 3481. PubMed
14. Zhou J, et al. 2015. J Immunol. 194:4688. PubMed
15. Judge CJ, et al. 2017. J Leukoc Biol. 102:171. PubMed
16. Na I, et al. 2013. Haematologica. 98:23. PubMed
17. Hansen IS, et al. 2018. Nat Commun. 9:863. PubMed
18. Chandele A, et al. 2016. J Virol. 90(24):11259-11278. PubMed
19. Kiniry B, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.100. PubMed
20. Roberta Zappasodi et al. 2018. Cancer cell. 33(6):1017-1032 . PubMed
21. Rajamanickam V, et al. 2021. Cancer Immunol Res. 9:602. PubMed
22. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
23. Lutter L, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1567. PubMed
24. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
25. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
26. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
27. Khaitan A, et al. 2016. PLoS One. 11: 0161786. PubMed
28. Hazenberg MD, et al. 2019. Blood Adv. 2.659722222. PubMed
29. Bochem J, et al. 2019. PLoS One. 14:e0221301. PubMed
30. Del Alcazar D, et al. 2019. Cell Rep. 28:3047. PubMed
31. Leclerc M, et al. 2019. Nat Commun. 10:3345. PubMed
32. Krishnan S, et al. 2021. Clin Exp Immunol. 203:458. PubMed
33. Golebski K, et al. 2021. Immunity. 54(2):291-307.e7. PubMed
34. Yoshida R, et al. 2022. Cancer Res. :. PubMed
35. Gorman JA, et al. 2019. Front Immunol. 10:44. PubMed
36. Khuzwayo S, et al. 2021. Front Immunol. 12:631410. PubMed
37. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
38. Verma K, et al. 2017. PLoS One.. 10.1371/journal.pone.0183828. PubMed
39. Berry MR et al. 2017. Cell. 170(5):860-874 . PubMed
40. Janssen JJE, et al. 2022. Am J Physiol Endocrinol Metab. 322:E141. PubMed
41. Chen Y, et al. 2020. Cell. 1496:183. PubMed
42. Hood SP, et al. 2020. Elife. 9:00. PubMed
43. Chen J, et al. 2017. Sci Rep. 10.1038/s41598-017-11056-9. PubMed
44. FitzPatrick MEB, et al. 2021. Cell Rep. 34:108661. PubMed
45. Bal S, et al. 2016. Nat Immunol. 10.1038/ni.3444. PubMed
46. Rousset F, et al. 2018. Mol Ther Nucleic Acids. 14:351. PubMed
47. Goc J, et al. 2021. Cell. :. PubMed
48. Martin GE, et al. 2018. Front Immunol. 1.019444444. PubMed
49. Harris LD, et al. 2020. Front Cell Infect Microbiol. 10:120. PubMed
50. Corgnac S, et al. 2021. STAR Protocols. 2(1):100267. PubMed
51. Tsai S, et al. 2018. Cell Metab. 28:922. PubMed

Mature T and NK T cells, thymocyte differentiation

1. Barclay N, et al. 1993. The Leucocyte FactsBook. Academic Press. San Diego.
2. Beverly P, et al. 1981. Eur. J. Immunol. 11:329.
3. Lanier L, et al. 1986. J. Immunol. 137:2501-2507.